Abstract. In a previous study, we reported that a gene mutation of repeat in toxin E (RtxE), a transporter of cytotoxic factors, resulted in a significant impairment of epithelial cell cytotoxicity in Vibrio vulnificus, and that the expression of the rtxE gene was induced by the exposure to the host cells. In this study, we evaluated and compared the effects of coculture supernatants from V. vulnificus-infected INT-407 cells and either the V. vulnificus wild-type or rtxE mutant on the production of interleukin (IL)-8, a pro-inflammatory cytokine, as well as its underlying mechanisms in human intestinal epithelial cells. INT-407 cells were co-cultured with the wild-type V. vulnificus or the rtxE mutant strain to obtain the conditioned supernatants. IL-8 production and nuclear factor (NF)-κB activation from the INT-407 cells treated with each supernatant, were investigated. The co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells significantly induced lower levels of IL-8 production and promoter activation, NF-κB DNA binding activity, and NF-κB minimal promoter activation in human intestinal epithelial cells, than those from the wild-type V. vulnificus-infected INT-407 cells. Importantly, the reduced IL-8 production and NF-κB activity of the V. vulnificus rtxE mutant, were restored by co-culture supernatants from the rtxE-complemented V. vulnificus. On the whole, these results show that the rtxE gene of V. vulnificus performs a critical role in the secretion of factors from bacteria and host cells, which are involved in IL-8 production via the NF-κB activation pathway in host cells.
Introduction
Vibrio vulnificus is a gram-negative estuarine bacterium, and has been identified as a significant human pathogen. Mortality rates from primary septicemia are quite high (>50%) and death can occur within 1-2 days after the first signs of illness. V. vulnificus infection is characterized by septicemia and skin infections, accompanied in many cases by ulcers and edema (1, 2) . The majority of fatal cases are caused by septic shock (3), which results from a variety of V. vulnificus virulence factors, including capsular polysaccharides (CPS) (4-6), hemolysin (7) , siderophores (8) , and repeats in toxin (RTX) (9) (10) (11) (12) .
The V. vulnificus RTX toxins are comprised of 4 genes of 2 rtx operons: rtxA encodes for the toxin, rtxC encodes for an essential acylase of RtxA, rtxB/rtxE encodes for an ATPbinding cassette transporter of RtxA, and rtxD encodes for a gene of unknown function (9) . RtxE is a component of the type I secretion system (TISS), which is involved in the secretion of several virulence factors, such as RtxA, from the cells to the cell exterior (13) (14) (15) . Previously, we determined that a gene mutation of the rtxE gene in V. vulnificus can block the secretion of virulence factors, thereby resulting in a significant reduction in the cytotoxic activity of V. vulnificus. The expression of the rtxE gene was shown to be induced by the exposure to the host cells (10, 11) , thereby indicating that virulence factors can be secreted into the exterior via the RtxE-harboring TISS only after the bacteria make contact with the host cells.
Bacterial virulence factors, or the overproduction and dysregulation of the host cytokines during bacterial infection, result in septic shock or septicemia. These factors can persistently activate the generation of pro-inflammatory mediators including tumor necrosis factor-·, interleukin (IL)-1ß, IL-6, IL-8 and nitric oxide in the infected host (16, 17) .
The majority of these mediators show evidence of multiple biological effects, and have been identified as key mediators in the pathophysiological alterations noted in septic shock (18) (19) (20) . Immunotherapeutic intervention strategies that abrogate the biological activities of these mediators have been observed to exert a significant protective effect against the lethal effects of LPS (21, 22) . Previously, we reported that V. vulnificus infection induced IL-8 production in human intestinal epithelial cells via the nuclear factor (NF)-κB activation pathway (17) . IL-8 has also been shown to play a critical role in the pathogenesis of infectious diseases.
Therefore, in this study, in order to evaluate the role of RtxE in IL-8 production in human epithelial cells, we investigated and compared the effects of co-culture supernatants from host INT-407 cells and either the wild-type or the rtxE mutant of V. vulnificus on IL-8 production, as well as their underlying mechanisms. We demonstrated that RtxE, a cytotoxic factor transporter, performs a critical function in the secretion of factors, which are involved in IL-8 production via the NF-κB activation pathway in human intestinal epithelial cells.
Materials and methods
Cell cultures. Human intestinal epithelial cell-lines, INT-407 cells, were purchased from the American Type Culture Collection (Manassas, VA, USA) and maintained at 37˚C in 5% CO 2 in Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum (Gibco BRL, Grand Island, NY, USA) and antibiotics (10 units/ml penicillin G and 10 μg/ml streptomycin) (growth medium).
Bacterial strain and growth conditions. The V. vulnificus strain, MO6-24/O, used in this study was isolated from clinical patients, and the rtxE gene mutant and the rtxE-complemented strains were generated, as previously described (11) . For the infection experiments, the bacteria were grown at 30˚C in Luria-Bertani medium supplemented with 2% NaCl (LBS medium), and diluted to ~6x10 8 CFU/ml in LBS, then centrifuged and resuspended in antibiotic-free growth medium prior to the epithelial cell infection. Bacterial concentrations were confirmed via viable cell counts on LBS agar.
Infection protocol. Human intestinal epithelial cells were infected with V. vulnificus, as previously described (11, 12) . In brief, intestinal epithelial cells were grown in culture flasks at 37˚C in a 5% CO 2 incubator. The cells (3x10 6 ) were seeded onto culture dishes (10 ml medium/10-cm) and incubated for 24 h in antibiotic-free growth medium. Prior to infection, the bacteria were centrifuged for 3 min at 2,500 x g, resuspended and adjusted to ~6x10 8 CFU/ml in antibiotic and phenol redfree MEM. The bacterial suspensions were added to the epithelial cells at a multiplicity of infection (ratio of no. of bacteria to no. of epithelial cells) of 10, after which the infected cells were incubated in a 5% CO 2 incubator for 2 h at 37˚C in antibiotic and phenol red-free growth medium.
Preparation of co-culture supernatants from V. vulnificusinfected INT-407 cells.
Co-culture supernatants were obtained and harvested by centrifugation at 4,000 x g for 10 min at 4˚C. This was repeated once more with the resulting supernatant. The clarified supernatants were filtered through a 0.22 μM pore membrane to ensure the removal of any remaining bacterial cells and debris.
Transient transfection and dual luciferase reporter assay.
Human intestinal epithelial cells were transiently transfected with human IL-8 full promoter and IL-8/linker scanning (LS) mutation promoter, with NF-κB minimal promoter constructs, or pRL-TK reporter vector, as previously described (6) . In brief, intestinal epithelial cells were plated at a density of 2x10 4 cells in 24-well plates. After 24 h of culture, the INT-407 cells were transiently transfected with each of the human IL-8 full, IL-8/LS promoter constructs, NF-κB minimal promoter, or the pRL-TK Renilla luciferase reporter vector (Promega) by using the SuperFect method (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions. The transfected cells were incubated for 12 h at 37˚C in a 5% CO 2 incubator. The cells were washed in PBS, after which the cells were incubated with culture supernatants for 12 or 24 h. Afterwards, the cells were harvested and suspended for 20 min in 100 μl of lysis buffer. The supernatant fluid was harvested and assayed for luciferase activity using Dual Luciferase Reagent (Promega) in a luminometer. Results were normalized by Renilla luciferase activity, and were expressed as relative fold induction.
Reverse transcription polymerase chain reaction (RT-PCR).
Total RNA was prepared from the cells and reverse-transcribed into cDNA, after which the cDNA was amplified by PCR. Total cellular RNA was isolated via the single-step method, using easy-Blue reagent (Intron, Korea). The primers used were as follows: Human IL-8 (302 bp), 5'-ATGACTT CCAAGCTGGCCGTGGCT-3' (sense) and 5'-TTATGAATT CTCAGCCCTCTTCAAAAACTTCTC-3' (antisense); and ß-actin (373 bp), 5'-TTCTACAATGAGCTGCGTGTGGCT-3' (sense) and 5'-GCTTCTCCTTAATGTCACGCACGA-3' (antisense). The reactions were conducted in an MJ Thermal Cycler (Watertown, MA, USA) for 34 cycles of the following: Denaturing at 94˚C for 30 sec, annealing at 60˚C for 30 sec, and extending at 72˚C for 30 sec. After amplification, the RT-PCR products were separated on 2% (w/v) agarose gels and stained with ethidium bromide.
Preparation of cell lysates and Western blot analysis.
The cells were lysed in lysis buffer (50 mM Tris buffer, pH 7.5, containing 100 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, 50 μg/ml each of leupeptin, aprotinin and PMSF) by incubation on ice for 30 min. The lysates were then centrifuged at 13,000 x g at 4˚C for 15 min, and the supernatants were transferred to fresh tubes and stored at -70˚C until use. Protein concentrations of the lysates were determined by using the BCA™ Protein Assay Reagent A (Pierce, USA). Equal amounts (20 μg/ml) of whole cell lysates were subjected to sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were transferred onto a polyvinylidene fluoride membrane using the Semi-Phor unit (Hoefer Scientific Instruments). The membrane was then incubated with washing buffer (PBS solution containing 0.1% Tween-20) containing 1% bovine serum albumin for at least 1 h to block non-specific protein binding. Afterwards, the membrane was, respectively, treated with anti-ß-actin, anti-IκB· and antiphospho-IκB· antibodies (Santa Cruz Biotechnology, Inc.). After incubation with HRP-conjugated anti-rabbit antibody, immunoreactive proteins were detected with the ECL system (Amersham Biosciences, England). cells/dish) were seeded onto 60-mm culture dishes, cultured for 24 h in antibiotic-free growth medium, and then treated with co-culture supernatants for 1 h. The nuclear extracts were prepared as previously described (6) . In brief, the infected cells were washed twice in PBS and resuspended in hypotonic buffer (10 mM HEPES buffer, pH 7.9, containing 0.5 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT and 0.2 mM PMSF). After the cells were allowed to swell on ice for 10 min, a 10% solution of Nonidet P-40 was added and the cells were maintained for 15 min on ice. The homogenates were centrifuged for 15 min at 5,000 x g, and the resultant nuclear pellets were resuspended in 50 μl of low salt buffer (20 mM HEPES buffer, pH 7.9, containing 25% glycerol, 1.5 mM MgCl 2 and 0.2 mM PMSF) and then 50 μl of high salt buffer (20 mM HEPES buffer, pH 7.9, containing 25% glycerol, 1.5 mM MgCl 2 , 0.8 M KCl, 0.2 mM EDTA, 0.5 mM DTT and 0.2 mM PMSF) in a dropwise fashion. The nuclear extracts were centrifuged for 30 min at 20,500 x g at 4˚C. The nuclear extracts (10 μg of each one) were incubated for 30 min with the labeled oligonucleotides in 20 μl of binding buffer (10 mM Tris-HCl, pH 7.6, 500 mM KCl, 10 mM EDTA, 50% glycerol, 250 ng poly(dI-dC) and 1 mM dithiothreitol). The reaction mixture was analyzed by electrophoresis on a 4% polyacrylamide gel in 0.5X Tris borate buffer. An oligonucleotide harboring an NF-κB binding site (5'-CCGGTTAACAGA GGGGGCTTTCCGAG-3') was used as the probe. Specific binding was verified via competition experiments with a 50-fold excess of unlabeled, identical oligonucleotides of cAMP response element (CRE)-containing oligonucleotides.
Fluorescence microscopy. For fluorescence assay, human intestinal epithelial cells were seeded onto 24-well plates and treated for 3 h with different co-culture supernatants from V. vulnificus-infected INT-407 cells. The cells were washed with PBS, fixed with 4% paraformaldehyde for 30 min at room temperature, permeabilized for 10 min with 0.2% Triton X-100 in PBS, and blocked for 1 h with 1.5% fetal bovine serum in PBS. The cells were incubated with a rabbit anti-NF-κB p65 antibody (diluted 1:200) for 1 h at room temperature, and then incubated with fluorescein isothiocyanateconjugated secondary antibody (Santa Cruz Biotechnology). The cells were mounted with anti-fade mounting medium and examined using an Olympus IX71 fluorescence microscope.
Statistical analyses. Student's t-tests and one-way analysis of variance (ANOVA), followed by the Bonferroni method, were employed in order to determine statistical differences between the values of the various experimental and control groups. P-values of <0.05 were considered statistically significant.
Results

Co-culture supernatants from INT-407 cells infected by the V. vulnificus rtxE mutant significantly reduce IL-8 production in human intestinal epithelial cells.
IL-8 is a pro-inflammatory cytokine involved in the pathogenesis of V. vulnificus. Factors affecting IL-8 production can be secreted into the supernatant via the RtxE-harboring TISS when V. vulnificus makes direct contact with the host cells.
In this study, we wanted to evaluate whether co-culture supernatants from V. vulnificus-infected INT-407 cells can induce IL-8 production in intestinal epithelial cells. As we have described previously, the V. vulnificus rtxE gene plays a very crucial role in releasing factors into supernatants for IL-8 production in intestinal epithelial cells. Afterward, the supernatants were obtained, filtered, and utilized in further experiments. Co-culture supernatants from INT-407 cells infected with the V. vulnificus wild-type were used as the control. INT-407 cells were then treated with each of the coculture supernatants, and the expression levels of IL-8 mRNA and protein were determined.
As shown in Fig. 1 , co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells significantly reduced IL-8 mRNA in intestinal epithelial cells. In contrast, the expression of ß-actin mRNA was unaffected in the INT-407 cells treated with the co-culture supernatants of the rtxE gene mutant and host cells, thereby indicating that the reduced effects of the rtxE gene mutation on IL-8 expression were not the consequence of a general dampening of cellular activation (Fig. 1A) . Additionally, co-culture supernatants from rtxE mutant V. vulnificus-infected INT-407 cells significantly reduced IL-8 production in intestinal epithelial cells (Fig. 1B) . The growth rates of 2 V. vulnificus strains (the wild-type and rtxE mutant of V. vulnificus) did not differ significantly (data not shown).
Co-culture supernatants from rtxE mutant V. vulnificusinfected INT-407 cells significantly reduce IL-8 promoter activation in human intestinal epithelial cells.
In order to determine whether co-culture supernatants from either the rtxE mutant or the wild-type V. vulnificus-infected INT-407 cells differentially affect the activity of the IL-8 gene promoter, human intestinal epithelial cells were transiently transfected with the IL-8 promoter/luciferase construct (IL-8 full promoter, Fig. 2A) , and then treated with co-culture supernatants from the rtxE mutant or wild-type, after which the luciferase activity was assessed. As shown in Fig. 2B , the IL-8 full promoter construct was significantly stimulated with co-culture supernatants from the wild-type V. vulnificusinfected INT-407 cells. However, the stimulated levels were significantly lower in the co-culture supernatants from the rtxE mutant-infected INT-407 cells compared to those treated with co-culture supernatants from the wild-type V. vulnificusinfected INT-407 cells, thus indicating that co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells lacked the factor(s) involved in the activation of the IL-8 promoter.
NF-κB, NF-IL-6 and AP-1 are 3 transcriptional factors that are crucial for the regulation of IL-8 gene expression (23, 24) . Previously, we determined that the NF-κB site was required for IL-8 production after V. vulnificus infection in human intestinal epithelial cells (6, 17) . In order to directly investigate the role of a NF-κB site located between -80 and -71 of the IL-8 full promoter in co-culture supernatantstimulatory action, we introduced an LS mutation into the NF-κB site within the context of the -144/+44 construct (IL-8/ LS promoter, Fig. 2A ). As shown in Fig. 2B , the activation of co-culture supernatants from the wild-type V. vulnificusinfected INT-407 cell-dependent promoter, was significantly reduced, although it was still observed with the IL-8/LS promoter. The IL-8/LS promoter was not activated when the cells were treated with co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells. These results indicate that the rtxE gene of V. vulnificus plays a role in secreting factors from INT-407 cells and that V. vulnificus is involved in IL-8 production via the NF-κB activation pathway when the bacteria are co-cultured with host cells.
Co-culture supernatants from rtxE mutant V. vulnificusinfected INT-407 cells significantly reduce NF-κB DNA binding activity and IκB· phosphorylation compared to those from wild-type V. vulnificus-infected INT-407 cells.
To determine whether NF-κB activity was relevant to the reduced levels of IL-8 production in human epithelial cells treated with co-culture supernatants from rtxE mutant V. vulnificusinfected INT-407 cells, human intestinal epithelial cells were transiently transfected with NF-κB minimal promoter/ luciferase construct, followed by treatment with co-culture supernatants from V. vulnificus-infected INT-407 cells, and then the luciferase activity was determined. The NF-κB minimal promoter construct was potently stimulated with coculture supernatants from the wild-type V. vulnificus-infected INT-407 cells in a time-dependent fashion. However, the levels of NF-κB activation were significantly reduced in the co-culture supernatants from the rtxE mutant V. vulnificusinfected INT-407 cells (Fig. 3A) .
Also, in order to ascertain whether or not NF-κB activity was involved in the reduced levels of IL-8 production in intestinal epithelial cells treated with co-culture supernatants from rtxE mutant V. vulnificus-infected INT-407 cells, we analyzed the NF-κB DNA binding activity in the nuclear extracts of intestinal epithelial cells treated with each of the co-culture supernatants. As shown in Fig. 3B , the treatment of intestinal epithelial cells with co-culture supernatants from the wild-type V. vulnificus-infected INT-407 cells resulted in profound NF-κB binding activity. As we anticipated, the treatment with co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells significantly reduced NF-κB DNA binding activity in human intestinal epithelial cells. This result was in contrast to the one observed with the co-culture supernatants from the wild-type V. vulnificusinfected INT-407 cells, as determined by electrophoretic mobility shift assays using labeled oligonucleotides containing a consensus NF-κB site. This binding was recognized as specific, as it competed with an unlabeled, identical oligonucleotide, but not with an unrelated, non-specific oligonucleotide, and was absent in the nuclear extracts from the non-stimulated cells.
In the majority of cells, NF-κB exists in an inactive form in the cytoplasm, bound to the inhibitory IκB· proteins. The treatment of cells with various inducers results in the degradation of the IκB· proteins. The bound NF-κB is then released and translocated into the nucleus, where it activates the appropriate target genes. In order to further assess the involvement of IκB· degradation in the reduced NF-κB binding activity observed with co-culture supernatants from rtxE mutant V. vulnificus-infected INT-407 cells, we determined the levels of the IκB· protein via Western blot analysis using anti-IκB· mAb and anti-phospho-IκB· antibodies. As shown in Fig. 3C (Fig. 5) . The levels of IL-8/LS promoter activity were approximately the same in human intestinal epithelial cells treated with co-culture supernatants from the V. vulnificus wild-type, rtxE mutant, or rtxEcomplemented strains. with BAY11-7082, a specific inhibitor of NF-κB activation, resulted in a significant diminution of IL-8 production induced by co-culture supernatants from the wild-type or rtxEcomplemented V. vulnificus-infected INT-407 cells (Fig. 7) . The results clearly indicate that co-culture supernatants from V. vulnificus-infected INT-407 cells are involved in the production of IL-8 in human intestinal epithelial cells via NF-κB activation when the bacteria come into contact with the host cells.
Discussion
In this study, we hypothesized that the TISS transporter system of V. vulnificus could actively secrete factors into the supernatant when the bacteria make contact with host cells. Also, V. vulnificus causes the secretion of factors from host cells to the culture medium. The secreted factors from the bacteria and host cells can induce IL-8 production in human intestinal epithelial cells. Our results clearly demonstrate that co-culture supernatants from the rtxE mutant of V. vulnificus significantly induce lower levels of IL-8 production and NF-κB activity compared to those from the wild-type V. vulnificus-infected INT-407 cells, and that the reduction in levels induced by coculture supernatants from the rtxE mutant V. vulnificusinfected INT-407 cells was restored by those from the rtxEcomplemented V. vulnificus-infected INT-407 cells, thereby indicating that the rtxE mutant of V. vulnificus was defective in secreting factors involved in IL-8 production, whereas the wild-type of V. vulnificus could secrete those factors when co-cultured with INT-407 cells.
It remains unclear as to which factors are secreted into the supernatant via the TISS of V. vulnificus when the bacteria make direct contact with the host cells. Proteomic analysis studies are currently underway to compare the co-culture supernatants from wild-type, rtxE mutant, or rtxE-complemented V. vulnificus-infected INT-407 cells. The RtxA toxin is known to be secreted via the TISS, and its secretion has been shown to require the direct exposure of V. vulnificus to the host cells (11) . The RTX toxin induces cell rounding and increased permeability through tight cellular junctions due to the cross-linking of actin monomers, thus resulting in the depolymerization of actin stress fibers (25) . In a murine pulmonary cholera model, the RTX toxin mutants have demonstrated less severe pathology and reduced serum levels of pro-inflammatory IL-6 and murine macrophage inflammatory protein-2, thereby suggesting that RTX is relevant to the severity of acute inflammatory responses (26) . One consequence of cytolysis or cell damage is the release of intracellular contents, including cytoplasmic proteins, into the extracellular space and peripheral circulation (27) (28) (29) . An accumulation of secreted extracellular proteins from the host can contribute to increased blood viscosity, endothelial damage and microvascular thrombosis (30) . Therefore, we assume that the expressions of pro-inflammatory cytokines are induced by the virulence factors of V. vulnificus, including RTX toxins, and secreted endogenous proteins from the host.
The mechanism by which co-culture supernatants from rtxE mutant V. vulnificus-infected INT-407 cells, compared to those from wild-type V. vulnificus-infected INT-407 cells induced significant reductions in IL-8 production at the molecular level, remains to be clearly elucidated. However, several lines of evidence support the notion that the reduced IL-8 production described herein is closely correlated with the down-regulation of NF-κB activity in human intestinal epithelial cells treated with co-culture supernatants from rtxE mutant V. vulnificus-infected INT-407 cells. Co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells induced significantly lower levels of NF-κB promoter activation, NF-κB DNA binding activity, IκB· phosphorylation and NF-κB nuclear translocation than those from the wild-type V. vulnificus-infected INT-407 cells. Additionally, co-culture supernatants from the wild-type V. vulnificus-infected INT-407 cells strongly stimulated IL-8 promoter activation, and its stimulatory effect disappeared in the cells transfected with the IL-8/LS promoter harboring the LS mutation of the NF-κB sites. Finally, the reduced levels of NF-κB activities attributable to the co-culture supernatants from the rtxE mutant V. vulnificus-infected INT-407 cells were restored by those from the rtxE-complemented V. vulnificusinfected INT-407 cells. These results clearly indicate that the stimulatory effects of co-culture supernatants from the V. vulnificus-infected INT-407 cells on IL-8 production, were mediated via the κB site. We have previously reported that infection with V. vulnificus induced IL-8 production in human intestinal epithelial cells via NF-κB activation (6, 17) .
The results of the present study clearly demonstrate for the first time that RtxE, a transporter of cytotoxic factors, performs a crucial role in secreting factors from bacteria and host cells involved in the IL-8 production of human intestinal epithelial cells exposed to V. vulnificus. The results suggest that RtxE could possibly be utilized as a target in the regulation of V. vulnificus pathogenesis. 
